Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
10:10am, Tuesday, 30'th May 2023
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Pfizer's Heading for a Patent Cliff. Is the Stock Still a Buy?
05:30am, Tuesday, 30'th May 2023
Pfizer's older blockbusters are set to lose exclusivity soon, meaning billions of dollars in lost revenue. But the company's near-to-market candidates and products gained through acquisitions could sp
Pfizer: The New Oral Weight Loss Therapy Could Be A Game Changer
12:11am, Tuesday, 30'th May 2023
Pfizer has declined over 36% in the past two years, as investors worry about the company's growth post-COVID. The company's new oral weight loss therapy recently showed positive phase 2 data and could
The 3 Best Healthcare Stocks to Buy for June 2023
03:13pm, Monday, 29'th May 2023
Healthcare stocks have been trailing the market this year. Vanguard's Health Care ETF (NYSEARCA: VHT ) is down 5% on the year, compared with a 10% year-to-date gain in the benchmark S&P 500 index.
The Top Healthcare Stocks to Buy With $100
09:30am, Monday, 29'th May 2023
Pfizer is an old dog with big new tricks to come in the pharmaceutical sector. CVS has expanded beyond pharmacies to include health insurance and more.
Pfizer: Not Quite Dead Money Walking
09:00am, Monday, 29'th May 2023
PFE's historical stock performance remains mediocre compared to its pharmaceutical peers, even after adjusting for dividends. Combined with its decelerating COVID-19 portfolio and $22B worth of annual
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income
07:25am, Saturday, 27'th May 2023
Pfizer is an attractive option for dividend investors at the moment. Using dollar-cost averaging, you won't need much money to get started.
3 No-Brainer Stocks to Buy for Under $100 Right Now
06:14am, Saturday, 27'th May 2023
CRISPR Therapeutics could soon win approval for its first product. Novocure has big news on the way in a matter of days.
Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines
04:55pm, Friday, 26'th May 2023
Biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies' COVID-19 vaccines infringe its
Pfizer weight loss drug may be as effective as competitors: Study
12:58pm, Friday, 26'th May 2023
Yahoo Finance Live health care reporter Anjalee Khemlani details the clinical trial results of Pfizer's weight loss drug Danuglipron, how it compares to Novo Nordisk's Ozempic, and examines the adopti
Pfizer's (PFE) COVID-19 Oral Treatment Gets FDA Nod in Adults
12:20pm, Friday, 26'th May 2023
Per the FDA, Pfizer's (PFE) Paxlovid is the first oral antiviral pill approved in the United States to treat COVID-19 in adults. The drug was granted emergency use authorization by the FDA in 2021.
The dark side of the weight-loss drug craze: Eating disorders, medication shortages, dangerous knock-offs
10:04am, Friday, 26'th May 2023
A national obsession with a new class of weight-loss drugs is turning dangerous, doctors and researchers say, as many patients are inappropriately prescribed Wegovy, Ozempic and similar medications an
Why Pfizer Stock Slipped by 2% Today
06:03pm, Thursday, 25'th May 2023
The pharmaceutical giant won approval for a high-profile drug. But it might have been a case of too little, too late for some investors.
Pfizer trades at pre-pandemic levels, frustrating investors
05:49pm, Thursday, 25'th May 2023
Pfizer trades at pre-pandemic levels, frustrating investors.
Can Pfizer Stock Double Your Money in 3 Years?
01:00pm, Thursday, 25'th May 2023
Pfizer's stock price has languished of late for a multitude of reasons. The drugmaker's shares might be grossly undervalued considering its encouraging prospects in type 2 diabetes and weight loss.
